| |
| |
|
| Insider
Information: |
Marriott Thomas B III |
| Relationship: |
VP, Development Research |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
11,431 |
|
|
Indirect Shares
|
2,300 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,731 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NPS Pharmaceuticals Inc |
NPSP |
VP, Development Research |
2005-09-01 |
11,431 |
2005-05-16 |
2,300 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-09-01 |
4 |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
14,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-09-01 |
4 |
AS |
$9.94 |
$29,820 |
D/D |
(3,000) |
11,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-08-01 |
4 |
AS |
$10.86 |
$32,580 |
D/D |
(3,000) |
11,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-08-01 |
4 |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
14,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-07-01 |
4 |
AS |
$11.09 |
$33,279 |
D/D |
(3,000) |
11,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-07-01 |
4 |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
14,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-06-01 |
4/A |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
14,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-06-01 |
4/A |
AS |
$11.51 |
$34,530 |
D/D |
(3,000) |
11,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-06-01 |
4 |
OE |
$11.51 |
$34,530 |
D/D |
3,000 |
2,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-16 |
4 |
S |
$12.64 |
$78,460 |
D/D |
(6,208) |
5,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-16 |
4 |
S |
$12.80 |
$82,454 |
I/I |
(6,441) |
2,300 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-16 |
4/A |
S |
$12.64 |
$78,460 |
D/D |
(6,208) |
11,431 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-02 |
4/A |
OE |
$8.25 |
$24,750 |
D/D |
3,000 |
20,693 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-02 |
4/A |
AS |
$12.15 |
$36,450 |
D/D |
(3,000) |
17,639 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-05-02 |
4 |
OE |
$12.15 |
$36,450 |
D/D |
3,000 |
20,380 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-04-01 |
4/A |
OE |
$6.63 |
$23,288 |
D/D |
3,000 |
20,693 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-04-01 |
4/A |
AS |
$12.78 |
$38,329 |
D/D |
(3,000) |
17,639 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2005-04-01 |
4 |
OE |
$12.78 |
$38,328 |
D/D |
3,000 |
23,380 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-05-04 |
4 |
OE |
$6.63 |
$19,875 |
D/D |
3,000 |
20,639 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-05-03 |
4 |
AS |
$25.00 |
$75,000 |
D/D |
(3,000) |
17,639 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-04-01 |
4 |
AS |
$28.46 |
$85,380 |
D/D |
(3,000) |
20,339 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-04-01 |
4 |
OE |
$6.63 |
$19,875 |
D/D |
3,000 |
23,339 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-03-01 |
4 |
AS |
$30.02 |
$90,060 |
D/D |
(3,000) |
20,339 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-03-01 |
4 |
OE |
$6.63 |
$19,875 |
D/D |
3,000 |
23,339 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
VP, Development Research |
• – – |
2004-02-02 |
4 |
S |
$33.91 |
$101,727 |
D/D |
(3,000) |
20,339 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
